Skip to content

Safety of Undenatured Collagen Type II (UCII) Supplement in Healthy Volunteer

Safety of Undenatured Collagen Type II (UCII) Supplement in Healthy Volunteer

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05002634
Enrollment
60
Registered
2021-08-12
Start date
2021-08-05
Completion date
2022-07-31
Last updated
2021-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health, Subjective

Brief summary

This study will be evaluated safety of undenatured collagen type II (UCII) supplement in 60 healthy volunteer. Liver function test, renal function test, and adverse event will be assessed.

Detailed description

This study will be evaluated safety of undenatured collagen type II (UCII) supplement in 60 healthy volunteer. The undenatured collagen type II (UCII) supplement 40 mg will be taken once daily for 2 months. Liver function test, renal function test, and adverse event will be assessed before and after taking for 1 and 2 months.

Interventions

DIETARY_SUPPLEMENTundenatured collagen type II (UCII) supplement

The undenatured collagen type II (UCII) supplement 40 mg will be taken once daily for 2 months.

Sponsors

Chulalongkorn University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 20-60 years * No taking collagen supplement more than 2 weeks * No collagen and protein allergy * No liver and renal disease * Have a willingness to participate in the study

Exclusion criteria

* Uncontrolled disease * Have complication symptom during study * Pregnancy or lactation * Cannot follow the protocol * During participated in other studies

Design outcomes

Primary

MeasureTime frameDescription
Aspartate aminotransferase value2 monthsAspartate aminotransferase value (U/L) in blood sample

Secondary

MeasureTime frameDescription
Alkaline phosphatase value2 monthsAlkaline phosphatase value (U/L) in blood sample
Alanine transaminase value2 monthsAlanine transaminase value(U/L) in blood sample
Blood urea nitrogen value2 monthsBlood urea nitrogen value (mg/dl) in blood sample
Creatinine value2 monthsCreatinine value (mg/dl) in blood sample
Adverse event2 monthsusing questionnaire (Yes or No)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026